Cargando…
Site-level variability in the processes of care and outcomes over time among patients with COVID-19 and myocardial injury: Insights from the American Heart Association's COVID-19 Cardiovascular Disease Registry
BACKGROUND: Elevated cardiac troponin (cTn) levels in patients with COVID-19 has been associated with worse outcomes. Guidelines on best practices of those patients remain uncertain. METHODS: We included patients with COVID-19 and cTn above the assay-specific upper limit of normal (ULN) enrolled in...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894823/ https://www.ncbi.nlm.nih.gov/pubmed/36779177 http://dx.doi.org/10.1016/j.ahjo.2023.100265 |
_version_ | 1784881814630825984 |
---|---|
author | Sammour, Yasser M. Spertus, John A. Kennedy, Kevin Morrow, David A. Daniels, Lori B. Jones, Phil Alger, Heather Stevens, Laura Shah, Alpesh Goel, Sachin S. de Lemos, James A. Hayek, Salim S. Sutton, Nadia R. Kleiman, Neal S. |
author_facet | Sammour, Yasser M. Spertus, John A. Kennedy, Kevin Morrow, David A. Daniels, Lori B. Jones, Phil Alger, Heather Stevens, Laura Shah, Alpesh Goel, Sachin S. de Lemos, James A. Hayek, Salim S. Sutton, Nadia R. Kleiman, Neal S. |
author_sort | Sammour, Yasser M. |
collection | PubMed |
description | BACKGROUND: Elevated cardiac troponin (cTn) levels in patients with COVID-19 has been associated with worse outcomes. Guidelines on best practices of those patients remain uncertain. METHODS: We included patients with COVID-19 and cTn above the assay-specific upper limit of normal (ULN) enrolled in the American Heart Association's COVID-19 registry between March 2020–January 2021. Site-level variability in invasive coronary angiography, LVEF assessment, ICU utilization, and inpatient mortality were determined by calculating adjusted median odds ratio (MOR) using hierarchical logistic regression models. Temporal trends were assessed with Cochran-Armitage trend test. RESULTS: Among 32,636 patients, we included 6234 (19.4 %) with cTn above ULN (age 68.7 ± 16.0 years, 56.5 % male, 51.5 % Caucasian), of whom 1365 (21.6 %) had ≥5-fold elevations. Across 55 sites, the median rate of invasive coronary angiography was 0.1 % with adjusted MOR 1.5(1.0,2.3), median LVEF assessment was 25.5 %, MOR 3.0(2.2,3.9), ICU utilization was 41.7 %, MOR 2.2(1.8,2.6), and mortality was 20.9 %, MOR 1.7(1.5,2.0). Over time, we noted a significant increase in invasive coronary angiography (p-trend = 0.001), and LVEF assessment (p-trend<0.001), and reduction in mortality (p-trend<0.001), without significant change in ICU admissions (p-trend = 0.08). Similar variability and temporal trends were seen among patients with ≥5-fold cTn elevation. CONCLUSIONS: The use of invasive coronary angiography among patients with COVID-19 and myocardial injury was very low during the early pandemic. We found moderate institutional variability in processes of care with an uptrend in invasive catheterization and LVEF assessment, and downtrend in mortality. Comparative effectiveness studies are needed to examine whether variability in care is associated with differences in outcomes. |
format | Online Article Text |
id | pubmed-9894823 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Authors. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98948232023-02-06 Site-level variability in the processes of care and outcomes over time among patients with COVID-19 and myocardial injury: Insights from the American Heart Association's COVID-19 Cardiovascular Disease Registry Sammour, Yasser M. Spertus, John A. Kennedy, Kevin Morrow, David A. Daniels, Lori B. Jones, Phil Alger, Heather Stevens, Laura Shah, Alpesh Goel, Sachin S. de Lemos, James A. Hayek, Salim S. Sutton, Nadia R. Kleiman, Neal S. Am Heart J Plus Research Paper BACKGROUND: Elevated cardiac troponin (cTn) levels in patients with COVID-19 has been associated with worse outcomes. Guidelines on best practices of those patients remain uncertain. METHODS: We included patients with COVID-19 and cTn above the assay-specific upper limit of normal (ULN) enrolled in the American Heart Association's COVID-19 registry between March 2020–January 2021. Site-level variability in invasive coronary angiography, LVEF assessment, ICU utilization, and inpatient mortality were determined by calculating adjusted median odds ratio (MOR) using hierarchical logistic regression models. Temporal trends were assessed with Cochran-Armitage trend test. RESULTS: Among 32,636 patients, we included 6234 (19.4 %) with cTn above ULN (age 68.7 ± 16.0 years, 56.5 % male, 51.5 % Caucasian), of whom 1365 (21.6 %) had ≥5-fold elevations. Across 55 sites, the median rate of invasive coronary angiography was 0.1 % with adjusted MOR 1.5(1.0,2.3), median LVEF assessment was 25.5 %, MOR 3.0(2.2,3.9), ICU utilization was 41.7 %, MOR 2.2(1.8,2.6), and mortality was 20.9 %, MOR 1.7(1.5,2.0). Over time, we noted a significant increase in invasive coronary angiography (p-trend = 0.001), and LVEF assessment (p-trend<0.001), and reduction in mortality (p-trend<0.001), without significant change in ICU admissions (p-trend = 0.08). Similar variability and temporal trends were seen among patients with ≥5-fold cTn elevation. CONCLUSIONS: The use of invasive coronary angiography among patients with COVID-19 and myocardial injury was very low during the early pandemic. We found moderate institutional variability in processes of care with an uptrend in invasive catheterization and LVEF assessment, and downtrend in mortality. Comparative effectiveness studies are needed to examine whether variability in care is associated with differences in outcomes. The Authors. Published by Elsevier Inc. 2023-03 2023-02-03 /pmc/articles/PMC9894823/ /pubmed/36779177 http://dx.doi.org/10.1016/j.ahjo.2023.100265 Text en © 2023 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Research Paper Sammour, Yasser M. Spertus, John A. Kennedy, Kevin Morrow, David A. Daniels, Lori B. Jones, Phil Alger, Heather Stevens, Laura Shah, Alpesh Goel, Sachin S. de Lemos, James A. Hayek, Salim S. Sutton, Nadia R. Kleiman, Neal S. Site-level variability in the processes of care and outcomes over time among patients with COVID-19 and myocardial injury: Insights from the American Heart Association's COVID-19 Cardiovascular Disease Registry |
title | Site-level variability in the processes of care and outcomes over time among patients with COVID-19 and myocardial injury: Insights from the American Heart Association's COVID-19 Cardiovascular Disease Registry |
title_full | Site-level variability in the processes of care and outcomes over time among patients with COVID-19 and myocardial injury: Insights from the American Heart Association's COVID-19 Cardiovascular Disease Registry |
title_fullStr | Site-level variability in the processes of care and outcomes over time among patients with COVID-19 and myocardial injury: Insights from the American Heart Association's COVID-19 Cardiovascular Disease Registry |
title_full_unstemmed | Site-level variability in the processes of care and outcomes over time among patients with COVID-19 and myocardial injury: Insights from the American Heart Association's COVID-19 Cardiovascular Disease Registry |
title_short | Site-level variability in the processes of care and outcomes over time among patients with COVID-19 and myocardial injury: Insights from the American Heart Association's COVID-19 Cardiovascular Disease Registry |
title_sort | site-level variability in the processes of care and outcomes over time among patients with covid-19 and myocardial injury: insights from the american heart association's covid-19 cardiovascular disease registry |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894823/ https://www.ncbi.nlm.nih.gov/pubmed/36779177 http://dx.doi.org/10.1016/j.ahjo.2023.100265 |
work_keys_str_mv | AT sammouryasserm sitelevelvariabilityintheprocessesofcareandoutcomesovertimeamongpatientswithcovid19andmyocardialinjuryinsightsfromtheamericanheartassociationscovid19cardiovasculardiseaseregistry AT spertusjohna sitelevelvariabilityintheprocessesofcareandoutcomesovertimeamongpatientswithcovid19andmyocardialinjuryinsightsfromtheamericanheartassociationscovid19cardiovasculardiseaseregistry AT kennedykevin sitelevelvariabilityintheprocessesofcareandoutcomesovertimeamongpatientswithcovid19andmyocardialinjuryinsightsfromtheamericanheartassociationscovid19cardiovasculardiseaseregistry AT morrowdavida sitelevelvariabilityintheprocessesofcareandoutcomesovertimeamongpatientswithcovid19andmyocardialinjuryinsightsfromtheamericanheartassociationscovid19cardiovasculardiseaseregistry AT danielslorib sitelevelvariabilityintheprocessesofcareandoutcomesovertimeamongpatientswithcovid19andmyocardialinjuryinsightsfromtheamericanheartassociationscovid19cardiovasculardiseaseregistry AT jonesphil sitelevelvariabilityintheprocessesofcareandoutcomesovertimeamongpatientswithcovid19andmyocardialinjuryinsightsfromtheamericanheartassociationscovid19cardiovasculardiseaseregistry AT algerheather sitelevelvariabilityintheprocessesofcareandoutcomesovertimeamongpatientswithcovid19andmyocardialinjuryinsightsfromtheamericanheartassociationscovid19cardiovasculardiseaseregistry AT stevenslaura sitelevelvariabilityintheprocessesofcareandoutcomesovertimeamongpatientswithcovid19andmyocardialinjuryinsightsfromtheamericanheartassociationscovid19cardiovasculardiseaseregistry AT shahalpesh sitelevelvariabilityintheprocessesofcareandoutcomesovertimeamongpatientswithcovid19andmyocardialinjuryinsightsfromtheamericanheartassociationscovid19cardiovasculardiseaseregistry AT goelsachins sitelevelvariabilityintheprocessesofcareandoutcomesovertimeamongpatientswithcovid19andmyocardialinjuryinsightsfromtheamericanheartassociationscovid19cardiovasculardiseaseregistry AT delemosjamesa sitelevelvariabilityintheprocessesofcareandoutcomesovertimeamongpatientswithcovid19andmyocardialinjuryinsightsfromtheamericanheartassociationscovid19cardiovasculardiseaseregistry AT hayeksalims sitelevelvariabilityintheprocessesofcareandoutcomesovertimeamongpatientswithcovid19andmyocardialinjuryinsightsfromtheamericanheartassociationscovid19cardiovasculardiseaseregistry AT suttonnadiar sitelevelvariabilityintheprocessesofcareandoutcomesovertimeamongpatientswithcovid19andmyocardialinjuryinsightsfromtheamericanheartassociationscovid19cardiovasculardiseaseregistry AT kleimanneals sitelevelvariabilityintheprocessesofcareandoutcomesovertimeamongpatientswithcovid19andmyocardialinjuryinsightsfromtheamericanheartassociationscovid19cardiovasculardiseaseregistry |